Question 13 of 26

(demo test)

This man has every accepted indication for emergency posterior fossa surgery. The hematoma is 4 cm, well above the 3 cm threshold; there is brainstem compression and fourth ventricular encroachment threatening obstructive hydrocephalus; and he has declined to obtundation requiring intubation. Surgical decompression and evacuation is the only listed intervention with a realistic prospect of changing his outcome. The notorious feature of cerebellar hemorrhage is abrupt deterioration to coma after a deceptively stable period of observation, so the decision point is the appearance of brainstem signs or depressed consciousness, as here.

The anatomy explains the urgency. The posterior fossa is a small rigid compartment bounded by the tentorium and the foramen magnum, so a mass tolerated in a cerebral hemisphere rapidly produces pontine compression, upward transtentorial and downward tonsillar herniation, and fourth ventricular obstruction. Evacuation relieves both mechanisms at once, whereas a ventricular drain alone leaves the compressing clot and can promote upward herniation. Kuramatsu and colleagues, in a propensity-matched analysis, found evacuation associated with improved three-month survival though not with greater functional independence, and the 2022 American Heart Association guideline gives immediate evacuation a Class 1 recommendation when there is neurologic deterioration, brainstem compression, or hydrocephalus.

Intracerebral hemorrhage is medically managed almost everywhere except the cerebellum, where mass effect in a closed posterior fossa converts a survivable bleed into a lethal one within hours. Recognizing the surgical indications sits at the Core level of RITE content, because it is a time-critical decision every resident faces on call and the criteria are short and universally examined.

Incorrect Answers

• A. In the FAST trial recombinant activated factor VIIa reduced hematoma expansion but did not improve survival or functional outcome and increased arterial thromboembolic events; coagulation studies and platelets here are already normal. Choose this if the patient had a reversible coagulopathy, where targeted reversal would be indicated instead.
• C. Intravenous mannitol is a temporizing osmotic measure that may buy minutes while the operating room is readied, but it does not remove the clot. Choose this if the question asked for a bridging maneuver in a herniating patient en route to definitive treatment.
• D. Therapeutic hypothermia has an evidence base in comatose survivors of cardiac arrest, not in intracerebral hemorrhage, where it adds risk without benefit. Choose this if the vignette described return of spontaneous circulation after an out-of-hospital arrest.
• E. Rapid lowering of systolic pressure below 140 mm Hg was studied in INTERACT2 and ATACH-2 and is reasonable in supratentorial hemorrhage, with at best a modest effect on function; it does nothing about a compressing posterior fossa mass. Choose this if the patient had a small stable supratentorial hemorrhage with no mass effect.

Testing Pearls

• Cerebellar hemorrhage larger than 3 cm, or any size with brainstem compression, hydrocephalus, or declining consciousness, is a surgical emergency.
• It classically presents with abrupt vertigo, headache, vomiting, and inability to stand, with ipsilateral ataxia and gaze palsy but no hemiparesis.
• External ventricular drainage alone is inadequate for a compressing cerebellar clot and can precipitate upward transtentorial herniation.

References

1. Jankovic J, Mazziotta JC, Newman NJ, Pomeroy SL, editors. Bradley and Daroff's Neurology in Clinical Practice. 8th ed. Philadelphia, PA: Elsevier; 2022. p. 1027-1030.
2. Kuramatsu JB, Biffi A, Gerner ST, Sembill JA, Sprugel MI, Leasure A, et al. Surgical hematoma evacuation versus conservative treatment in cerebellar intracerebral hemorrhage. JAMA. 2019;322(14):1392-1403.
3. Greenberg SM, Ziai WC, Cordonnier C, Dowlatshahi D, Francis B, Goldstein JN, et al. 2022 guideline for the management of patients with spontaneous intracerebral hemorrhage. Stroke. 2022;53(7):e282-e361.
4. Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2008;358(20):2127-2137.